BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6408608)

  • 1. [Non-secretory myeloma of heavy mu-chain type].
    Leglise MC; Briere J; Abgrall JF; Hurez D
    Nouv Rev Fr Hematol (1978); 1983; 25(2):103-6. PubMed ID: 6408608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Mu' heavy chain type 'non-excretory' myeloma.
    Guglielmo P; Granata P; Di Raimondo F; Lombardo T; Giustolisi R; Cacciola E
    Scand J Haematol; 1982 Jul; 29(1):36-40. PubMed ID: 6812210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An unusual case of multiple myeloma diagnosed by a noticeable decrease in the serum M-component level].
    Kanoh T
    Rinsho Ketsueki; 1996 Dec; 37(12):1416-21. PubMed ID: 8997132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgM monoclonal gammopathy in plasmacytic neoplasms].
    Kraj M; Kopeć I; Rostkowska J; Pogłód R; Maj S
    Acta Haematol Pol; 1990; 21(2):153-65. PubMed ID: 2131715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light chain disease: report of an atypical case.
    Kardinal CG; Komorowski R
    South Med J; 1976 Sep; 69(9):1216-7. PubMed ID: 823646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological classification of 31 multiple myeloma patients.
    Qiu WX; Huang NH; Wu GH
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):79-83. PubMed ID: 2123037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.
    Roschke V; Hausner P; Kopantzev E; Pumphrey JG; Riminucci M; Hilbert DM; Rudikoff S
    Cancer Res; 1998 Feb; 58(3):535-41. PubMed ID: 9458102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heavy chain-producing variants of a mouse myeloma cell line.
    Morrison SL; Scharff MD
    J Immunol; 1975 Feb; 114(2 Pt 1):655-9. PubMed ID: 804509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies.
    Babusíková O; Stevulová L
    Neoplasma; 2004; 51(6):422-30. PubMed ID: 15640950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma in a patient at risk for AIDS.
    von Keyserlingk H; Baur R; Stein H; Hoeffken G; Thiel E
    Cancer Detect Prev; 1990; 14(3):403-4. PubMed ID: 2117486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incomplete picture of protein disorders in IgD multiple myeloma].
    Kraj M; Maj S; Mendek E; Snigurowicz J; Michalak T; Polkowska-Kulesza E
    Acta Haematol Pol; 1982; 13(3-4):147-55. PubMed ID: 6820866
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of surface mu-chain expression in human lymphoblastoid cell lines that do not produce light chains.
    Hendershot L; Levitt D
    J Immunol; 1984 Jan; 132(1):502-9. PubMed ID: 6418805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma- and mu-Heavy chain diseases and related disorders.
    Franklin EC
    J Clin Pathol Suppl (Assoc Clin Pathol); 1975; 6():65-71. PubMed ID: 830056
    [No Abstract]   [Full Text] [Related]  

  • 14. Mouse immunoglobulin mu heavy chain mRNA of Y5781, a high yield myeloma.
    Faust CH; Moore JM; Heim IE
    J Biol Chem; 1979 Nov; 254(21):10569-71. PubMed ID: 115861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of light and heavy chain distribution in a number of myeloma proteins.
    Mossafa N; Namaki E; Shamloo KD; Safavian A; Zavar A; Amin A
    Pahlavi Med J; 1976 Apr; 7(2):214-21. PubMed ID: 818598
    [No Abstract]   [Full Text] [Related]  

  • 16. [Initial central nervous system involvement in a case of non-secretory multiple myeloma].
    Calavia J; Loyola I; Richard C; Baro J; Recio M; Cuadrado MA; Zubizarreta A
    Sangre (Barc); 1993 Oct; 38(5):389-91. PubMed ID: 8140502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heavy chain diseases].
    Seligmann M
    Acquis Med Recent; 1978; ():151-61. PubMed ID: 120668
    [No Abstract]   [Full Text] [Related]  

  • 18. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
    Yeh YA; Pappas AA; Flick JT; Butch AW
    Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis.
    Valenzona HO; Pointer R; Ceredig R; Osmond DG
    Exp Hematol; 1996 Nov; 24(13):1521-9. PubMed ID: 8950236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.